Lazard Asset Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$971K Buy
185,384
+10,021
+6% +$34K ﹤0.01% 1236
2026
Q1
$309K Buy
+175,363
New +$380K ﹤0.01% 1500
2024
Q4
Sell
-29,720
Closed -$83K 2318
2024
Q3
$83K Buy
+29,720
New +$68K ﹤0.01% 1813
2022
Q3
Sell
-10,000
Closed -$21K 2345
2022
Q2
$21K Hold
10,000
﹤0.01% 2119
2022
Q1
$35K Buy
+10,000
New +$29K ﹤0.01% 1907
2021
Q4
Sell
-5,000
Closed -$36K 2308
2021
Q3
$36K Buy
+5,000
New +$42.8K ﹤0.01% 1824

Other funds holding CLOV

Lazard Asset Management's CLOV Position: Q2 2026 in Review

Lazard Asset Management increased its Clover Health Investments (CLOV) stake by 5.7% in Q2 2026, buying an estimated $34K and bringing the position to 185,384 shares worth $971K. The position accounts for ﹤0.01% of the portfolio, ranked #1236.

Lazard Asset Management first reported a position in CLOV in Q3 2021 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Lazard Asset Management held 185,384 shares of Clover Health Investments worth $971K as of Q2 2026.
  • Lazard Asset Management bought 10,021 Clover Health Investments shares in Q2 2026, an estimated $34K.
  • Clover Health Investments made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1236 holding.
  • Lazard Asset Management first reported a position in Clover Health Investments in Q3 2021 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.